The course focuses on the impact of the legal and regulatory system on research, products, and intellectual property for companies and academia and will include an overview of legal, corporate, intellectual property, ethical and regulatory issues impacting the biotechnology and pharmaceutical industries. Basic topics covered include intellectual property, patent law, and licensing in the field of biotechnology. Students will learn how to submit an idea, go through the disclosure and licensing process, and apply for a patent. Consideration is given to: (1) How do legal issues promote or hinder thedevelopment of technology, (2) What role should ethics and public health and safety concerns play in the law, (3) At what level should biotechnology be regulated: internationally, federally, at a state level, or locally. MED 283 is taught by Vern Norviel, JD, Partner at Wilson Sonsini Goodrich & Rosati, a patent attorney and the advisor to the M-TRAM program.
3 units · Medical Option (Med-Ltr-CR/NC)
The course focuses on the impact of the legal and regulatory system on research, products, and intellectual property for companies and academia and will include an overview of legal, corporate, intellectual property, ethical and regulatory issues impacting the biotechnology and pharmaceutical industries. Basic topics covered include intellectual property, patent law, and licensing in the field of biotechnology. Students will learn how to submit an idea, go through the disclosure and licensing process, and apply for a patent. Consideration is given to: (1) How do legal issues promote or hinder thedevelopment of technology, (2) What role should ethics and public health and safety concerns play in the law, (3) At what level should biotechnology be regulated: internationally, federally, at a state level, or locally. MED283 is taught by Vern Norviel, JD, Partner at Wilson Sonsini Goodrich & Rosati, a patent attorney and the advisor to the M-TRAM program.
Offered in Spring 2026 at Stanford University.